Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 4093
118th Congress(2023-2024)
Remote Opioid Monitoring Act of 2023
Introduced
Introduced
Introduced in House on Jun 14, 2023
Overview
Text
Introduced in House 
Jun 14, 2023
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Jun 14, 2023)
Jun 14, 2023
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 4093 (Introduced-in-House)


118th CONGRESS
1st Session
H. R. 4093


To provide for a study on the effects of remote monitoring on individuals who are prescribed opioids.

IN THE HOUSE OF REPRESENTATIVES

June 14, 2023

Mr. Balderson (for himself and Ms. Kelly of Illinois) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To provide for a study on the effects of remote monitoring on individuals who are prescribed opioids.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Remote Opioid Monitoring Act of 2023”.

SEC. 2. Providing for a study on the effects of remote monitoring on individuals who are prescribed opioids.

(a) In general.—Not later than 18 months after the date of enactment of this Act, the Comptroller General of the United States shall conduct a study and submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions and the Committee on Finance of the Senate a report on the use of remote monitoring with respect to individuals who are prescribed opioids.

(b) Report.—The report described in subsection (a) shall include—

(1) an assessment of scientific evidence related to the efficacy, individual outcomes, and potential cost savings associated with remote monitoring for individuals who are prescribed opioids compared to such individuals who are not so monitored;

(2) an assessment of the current prevalence of remote monitoring for individuals who are prescribed opioids, including the use of such monitoring for such individuals in other countries; and

(3) recommendations to improve availability, access, and coverage for remote monitoring for individuals who are prescribed opioids, including through changes to Federal health care programs (as defined in section 1128B of the Social Security Act (42 U.S.C. 1320a–7b)) and, if determined appropriate by the Comptroller General, an identification of cohorts of individuals who stand to benefit the most from remote monitoring when prescribed opioids.